Editorial
Published on 25 Apr 2024
Editorial: Promising therapeutic strategies for Alzheimer's disease: a focus on amyloid-β targeting
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1415641
Type at least 3 characters
1,977 articles
Articles
Case Report
Accepted on 24 Apr 2024
Case Report: Early-Onset Parkinson's Disease with Lower Limb Spasticity in a new DJ-1/PARK7 patient
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1400001
Brief Research Report
Published on 24 Apr 2024
EBV and multiple sclerosis: expression of LMP2A in MS patients
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1385233
- 129 views
Review
Accepted on 22 Apr 2024
Chlamydia pneumoniae in Alzheimer's Disease pathology
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1393293
Original Research
Accepted on 22 Apr 2024
Systematic genome-wide Mendelian randomization reveals the causal links between miRNAs and Parkinson's disease
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1385675
Opinion
Published on 22 Apr 2024
Potential roles of gangliosides in chemical-induced neurodegenerative diseases and mental health disorders
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1391413
- 248 views
Original Research
Accepted on 18 Apr 2024
Disrupted single-subject grey matter networks are associated with cognitive decline and cortical atrophy in Alzheimer's disease
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1366761
Editorial
Accepted on 16 Apr 2024
Editorial: New Insights into Atypical Alzheimer's Disease: From Clinical Phenotype to Biomarkers
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1414443
Original Research
Accepted on 15 Apr 2024
Effect of emotional stimulus on response inhibition in people with mild cognitive impairment: An event-related potential study
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1357435
Original Research
Accepted on 15 Apr 2024
EFhd2 co-aggregates with monomeric and filamentous tau in vitro
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1373410
Mini Review
Accepted on 15 Apr 2024
Therapeutic Developments for Neurodegenerative GM1 Gangliosidosis
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1392683
Original Research
Published on 12 Apr 2024
Retinal atrophy, inflammation, phagocytic and metabolic disruptions develop in the MerTK-cleavage-resistant mouse model
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1256522
- 293 views
Original Research
Published on 09 Apr 2024
Multi-pathological contributions toward atrophy patterns in the Alzheimer’s disease continuum
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1355695
- 331 views
Review
Accepted on 08 Apr 2024
Defining the concept of reserve in the motor domain: a systematic review
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1403065
Review
Published on 08 Apr 2024
Use of botulinum toxin in the management of dystonia in Parkinson’s disease
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1371601
- 334 views
Review
Published on 21 Mar 2024
The role of neurovascular coupling dysfunction in cognitive decline of diabetes patients
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2024.1375908
- 904 views